NVCT:

*Data is delayed | USD
after hours iconAfter Hours: Last |
quote price arrow down ()
Close
6.15quote price arrow down ()
52 week range
-
Loading...
  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High-
  • 52 Week High Date-
  • 52 Week Low-
  • 52 Week Low Date-

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High-
  • 52 Week High Date-
  • 52 Week Low-
  • 52 Week Low Date-
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On undefined

 

Profile

MORE
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The Company is developing two drug candidates: NXP800 and NXP900. NXP800 is an oral small molecule GCN2 activator, which is in a Phase 1b clinical trial for the treatment for platinum resistant, ARID1a-mutated ovarian carcinoma and in an investigator-sponsored clinical trial for the...
Ron Bentsur
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Michael Carson
Vice President - Finance
Address
1 Bridge Plaza, Suite 275
Fort Lee, NJ
07024
United States

Top Peers

SYMBOLLASTCHG%CHG
VOR
Vor Biopharma Inc
1.81+0.01+0.56%
VTGN
Vistagen Therapeutics Inc
4.44-0.11-2.42%
VIGL
Vigil Neuroscience Inc
3.52-0.02-0.56%
RZLT
Rezolute Inc
2.64+0.08+3.12%
IMUX
Immunic Inc
1.25UNCHUNCH